This inventor holds 1 USPTO granted patent. Top assignee: Klinikum Der Universitat Munchen. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Joseph Rosenecker: Innovator in Synthetic Compounds for Transfection
Introduction
Joseph Rosenecker is a notable inventor based in Muensing, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of synthetic compounds that enhance the efficiency of transfection in eukaryotic cells. His innovative work has the potential to advance various applications in genetic engineering and therapeutic interventions.
Latest Patents
Joseph Rosenecker holds a patent for a synthetic compound designed to improve the efficiency of transfection. The invention involves an amphiphilic block copolymer that includes a peptide residue with at least one targeting sequence and a nucleic acid binding sequence. This binding sequence consists of at least four consecutive positively charged amino acid residues at pH 7.4. The targeting sequence directs the compound to specific positions or structures within or on the surface of eukaryotic cells. Additionally, the synthetic compound features a hydrophobic moiety covalently linked to the peptide residue, which can include lipoic acid, lipoamide, tetradecyl, cholesteryl residues, or a peptide sequence with over 40% hydrophobic amino acid residues. This innovative approach has the potential to significantly enhance transfection efficiency.
Career Highlights
Joseph Rosenecker is affiliated with Klinikum der Universität München, where he continues to engage in research and development in the field of biotechnology. His work focuses on creating advanced solutions for cellular transfection, which is crucial for various biomedical applications.
Collaborations
Joseph collaborates with Shan Guan, contributing to the advancement of their shared research interests in synthetic compounds and transfection technologies.
Conclusion
Joseph Rosenecker's innovative contributions to synthetic compounds for transfection represent a significant advancement in biotechnology. His work has the potential to impact various fields, including genetic engineering and therapeutic development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile